IRIS Registry analysis reveals anti-VEGF monotherapies are similarly effective in improving vision

The authors compared real-world visual acuity in neovascular AMD patients who were treated with a single anti–VEGF drug for 1 year.

https://www.aao.org/editors-choice/iris-registry-analysis-reveals-anti-vegf-monothera

Comments

Popular posts from this blog

Save Your Vision at All Stages in Life

The Hidden Perils of Eye Rubbing

Zeaxanthin and Lutein Save the Eyes and Improve Brain Circulation